Volkert Arolt

Volkert Arolt's AcademicInfluence.com Rankings

Volkert Arolt

Biology

#8627

World Rank

#11734

Historical Rank

Genetics

#866

World Rank

#960

Historical Rank

biology Degrees

Download Badge

Biology

Volkert Arolt's Degrees

PhD Psychiatry University of Münster
Doctorate Medicine University of Münster

Why Is Volkert Arolt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Volkert Arolt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression (2018) (1816)
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions (2018) (1090)
Limbic Scars: Long-Term Consequences of Childhood Maltreatment Revealed by Functional and Structural Magnetic Resonance Imaging (2012) (809)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine (2006) (736)
Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group (2016) (725)
S100B in brain damage and neurodegeneration (2003) (604)
Human Fear Conditioning and Extinction in Neuroimaging: A Systematic Review (2009) (498)
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group (2017) (482)
Genomewide Association for Major Depressive Disorder: A possible role for the presynaptic protein Piccolo (2008) (410)
An international two–stage genome–wide search for schizophrenia susceptibility genes (1995) (382)
Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
Automatic Mood-Congruent Amygdala Responses to Masked Facial Expressions in Major Depression (2010) (309)
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. (2009) (297)
Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients (2003) (279)
Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression (2017) (259)
Cytokine Production and Serum Proteins in Depression (1995) (253)
Maternal posttraumatic stress response after the birth of a very low-birth-weight infant. (2004) (241)
Long-term cognitive and emotional consequences of mild traumatic brain injury (2010) (237)
Functional anatomy of visuo-spatial working memory during mental rotation is influenced by sex, menstrual cycle, and sex steroid hormones (2007) (233)
Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression (2003) (230)
Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data. (2016) (227)
Brain morphometric biomarkers distinguishing unipolar and bipolar depression. A voxel-based morphometry-pattern classification approach. (2014) (223)
Childhood maltreatment is associated with an automatic negative emotion processing bias in the amygdala (2013) (207)
Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. (2009) (207)
Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. (2011) (193)
Review of Immunological and Immunopathological Findings in Schizophrenia (2001) (192)
Neurotrophic Effects of Electroconvulsive Therapy: A Proton Magnetic Resonance Study of the Left Amygdalar Region in Patients with Treatment-Resistant Depression (2003) (186)
Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium☆ (2017) (183)
Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex (2003) (182)
Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. (1996) (182)
5-HTTLPR Biases Amygdala Activity in Response to Masked Facial Expressions in Major Depression (2008) (178)
Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. (2005) (172)
Inflammatory markers in major depression and melancholia. (2001) (171)
The Interleukin 1 Beta (IL1B) Gene Is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression (2010) (168)
Detection of Facial Expressions of Emotions in Depression (2001) (166)
Neuropeptide S receptor gene — converging evidence for a role in panic disorder (2011) (164)
Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression (2008) (164)
Individual differences in alexithymia and brain response to masked emotion faces (2010) (160)
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF (2004) (155)
Hippocampal Atrophy in Major Depression: a Function of Childhood Maltreatment Rather than Diagnosis? (2014) (149)
Association of the COMT val158met Variant with Antidepressant Treatment Response in Major Depression (2008) (149)
Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham‐controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain (2003) (149)
Neural correlates of trait anxiety in fear extinction (2010) (149)
Defining the human hippocampus in cerebral magnetic resonance images—An overview of current segmentation protocols (2009) (148)
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology (2001) (146)
Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response. (2014) (143)
Cognitive dysfunction in mice deficient for TNF‐ and its receptors (2008) (142)
The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models (2012) (141)
MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy (2016) (140)
Oxytocin Receptor Gene Methylation: Converging Multilevel Evidence for a Role in Social Anxiety (2015) (138)
Effect of Cognitive-Behavioral Therapy on Neural Correlates of Fear Conditioning in Panic Disorder (2013) (138)
Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study. (2007) (137)
Theory of Mind in first-episode schizophrenia patients: Correlations with cognition and personality traits (2010) (136)
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. (2006) (136)
Different immune patterns in melancholic and non-melancholic major depression (2001) (132)
Reward Processing in Unipolar and Bipolar Depression: A Functional MRI Study (2015) (132)
Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment (2000) (131)
Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients (2005) (129)
Insular and Hippocampal Gray Matter Volume Reductions in Patients with Major Depressive Disorder (2014) (126)
ERP indices for response inhibition are related to anxiety-related personality traits (2010) (124)
Vascular Endothelial Growth Factor Protects Cultured Rat Hippocampal Neurons against Hypoxic Injury via an Antiexcitotoxic, Caspase-Independent Mechanism (2002) (122)
Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex (2016) (120)
Serotonergic genes modulate amygdala activity in major depression (2007) (119)
Impact of Working Memory Load on fMRI Resting State Pattern in Subsequent Resting Phases (2009) (118)
Amygdala reactivity predicts automatic negative evaluations for facial emotions (2007) (116)
Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response. (2009) (116)
Psychological impact on women after second and third trimester termination of pregnancy due to fetal anomalies versus women after preterm birth—a 14-month follow up study (2009) (116)
Association between IL-8 cytokine and cognitive performance in an elderly general population—The MEMO-Study (2008) (115)
Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. (2007) (114)
Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. (2013) (112)
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response (2015) (111)
Major depressive disorder is associated with elevated monocyte counts (1996) (110)
Predicting treatment response to cognitive behavioral therapy in panic disorder with agoraphobia by integrating local neural information. (2015) (110)
Autocrine S100B effects on astrocytes are mediated via RAGE (2007) (109)
Immunological Dysfunction in Schizophrenia: A Systematic Approach (1998) (109)
Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder (2008) (109)
Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study (2005) (108)
S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia (2004) (107)
Spatial processing of facial emotion in patients with unipolar depression: a longitudinal study. (2004) (107)
S100B and response to treatment in major depression: a pilot study (2003) (106)
Deficiencies of the T and natural killer cell system in major depressive disorder T regulatory cell defects are associated with inflammatory monocyte activation (2016) (106)
Elevated plasma levels of S-100b protein in schizophrenic patients (1999) (106)
Obesity and major depression: Body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations (2015) (105)
Increased CD56+ natural killer cells and related cytokines in major depression. (1996) (105)
Alexithymic features and automatic amygdala reactivity to facial emotion (2008) (104)
Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: An fMRI and pattern classification study (2014) (103)
Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex (2013) (103)
Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? (2012) (102)
Trauma and grief 2–7 years after termination of pregnancy because of fetal anomalies – a pilot study (2005) (101)
Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression (2010) (101)
The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
S-100B is increased in melancholic but not in non-melancholic major depression. (2001) (99)
MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy (2014) (98)
Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia (1995) (98)
Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: associations with anhedonia. (2013) (96)
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. (2011) (94)
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia (2009) (93)
Cross-Disorder Analysis of Bipolar Risk Genes: Further Evidence of DGKH as a Risk Gene for Bipolar Disorder, but also Unipolar Depression and Adult ADHD (2011) (92)
Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder. (2016) (92)
S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury (2004) (90)
Neuroimaging differences in spatial cognition between men and male-to-female transsexuals before and during hormone therapy. (2010) (90)
Reduced Awareness of Others’ Emotions in Unipolar Depressed Patients (2005) (87)
Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium (2017) (87)
Neuropeptide-S (NPS) Receptor Genotype Modulates Basolateral Amygdala Responsiveness to Aversive Stimuli (2011) (84)
S100B in schizophrenic psychosis. (2004) (84)
A combined functional in vivo measure for primary and secondary auditory cortices (2000) (83)
The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment (2005) (82)
Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype (2010) (82)
Associations between Major Depression, Bipolar Disorders, Dysthymia and Cardiovascular Diseases in the General Adult Population (2006) (82)
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis (2016) (81)
Discriminating unipolar and bipolar depression by means of fMRI and pattern classification: a pilot study (2013) (81)
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium (2019) (80)
Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition (2004) (80)
Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol (2007) (80)
Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation (2012) (79)
Mediation of the influence of childhood maltreatment on depression relapse by cortical structure: a 2-year longitudinal observational study. (2019) (79)
COMPRI--an instrument to detect patients with complex care needs: results from a European study. (2001) (78)
Attachment avoidance modulates neural response to masked facial emotion (2009) (78)
The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity (2017) (74)
Production of cytokines in acute schizophrenic psychosis (1996) (73)
Working‐memory fMRI reveals cingulate hyperactivation in euthymic major depression (2009) (73)
Cytokine levels in major depression are related to childhood trauma but not to recent stressors (2016) (73)
Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank (2019) (72)
A voxel‐based diffusion tensor imaging study in unipolar and bipolar depression (2017) (71)
Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain (2012) (71)
148th Annual Meeting of the American Psychiatric Association (1996) (71)
Catechol-O-methyltransferase gene variation: Impact on amygdala response to aversive stimuli (2012) (70)
Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy (2008) (70)
Childhood adversity impacts on brain subcortical structures relevant to depression. (2017) (70)
fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder (2007) (69)
Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression (2008) (69)
Disadvantage of Social Sensitivity: Interaction of Oxytocin Receptor Genotype and Child Maltreatment on Brain Structure (2016) (69)
Pharmacogenetics of antidepressant response: A polygenic approach (2016) (69)
HTR2A gene variation is involved in antidepressant treatment response (2010) (68)
Attention training in the cognitive rehabilitation of schizophrenic patients:a review of efficacy studies (2001) (68)
Persistent non-verbal memory impairment in remitted major depression - caused by encoding deficits? (2010) (67)
Association of Serotonin Transporter Gene AluJb Methylation with Major Depression, Amygdala Responsiveness, 5-HTTLPR/rs25531 Polymorphism, and Stress (2017) (67)
The Association between Depressive Mood and Cognitive Performance in an Elderly General Population – The MEMO Study (2006) (66)
Moderators of the relationship between depression and cardiovascular disorders: a systematic review. (2012) (66)
Clinical characteristics of inflammation-associated depression: Monocyte gene expression is age-related in major depressive disorder (2015) (66)
Norepinephrine and Serotonin Transporter Genes: Impact on Treatment Response in Depression (2010) (66)
Dynamics of Defensive Reactivity in Patients with Panic Disorder and Agoraphobia: Implications for the Etiology of Panic Disorder (2012) (66)
Tumor Necrosis Factor Gene Variation Predicts Hippocampus Volume in Healthy Individuals (2012) (66)
Serotonin transporter gene and childhood trauma — a G × E effect on anxiety sensitivity (2011) (64)
Meta‐analysis argues for a female‐specific role of MAOA‐uVNTR in panic disorder in four European populations (2012) (63)
Alexithymia is related to differences in gray matter volume: A voxel-based morphometry study (2013) (62)
Associations between depression subtypes, depression severity and diet quality: cross-sectional findings from the BiDirect Study (2015) (62)
Increased amygdala activation during automatic processing of facial emotion in schizophrenia (2010) (62)
Diagnosing Delirium in Older Hospitalized Adults with Dementia: Adapting the Confusion Assessment Method to International Classification of Diseases, Tenth Revision, Diagnostic Criteria (2012) (62)
The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and sex hormones (2008) (62)
DISSOCIATIVE DISORDERS AND TRAUMATIC CHILDHOOD EXPERIENCES IN TRANSSEXUALS (2003) (61)
Neural activation underlying acute grief in women after the loss of an unborn child. (2009) (61)
The experience of basic emotions in schizophrenia with and without affective negative symptoms. (2003) (61)
Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions (2014) (61)
A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts (2020) (60)
Amygdala activation during masked presentation of emotional faces predicts conscious detection of threat-related faces (2006) (60)
[Psychiatric disorders in hospitalized internal medicine and surgical patients. Prevalence and need for treatment]. (1995) (60)
Affective priming in schizophrenia with and without affective negative symptoms (2003) (60)
Serotonin transporter polymorphism (5‐HTTLPR) association with melancholic depression: a female specific effect? (2008) (59)
Epigenetic signature of panic disorder: A role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation? (2013) (59)
The Limbic System in Youth Depression: Brain Structural and Functional Alterations in Adolescent In-patients with Severe Depression (2018) (58)
Complicated grief after traumatic loss (2007) (57)
Chromosome 4q31‐34 panic disorder risk locus: Association of neuropeptide Y Y5 receptor variants (2008) (57)
Prefrontal gray matter volume mediates genetic risks for obesity (2017) (57)
Establishing the bidirectional relationship between depression and subclinical arteriosclerosis – rationale, design, and characteristics of the BiDirect Study (2014) (57)
Are you gonna leave me? Separation anxiety is associated with increased amygdala responsiveness and volume. (2015) (55)
Euphoric mania and rapid transcranial magnetic stimulation. (2000) (55)
Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing (2016) (55)
Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders? (2019) (54)
Differential Abnormal Pattern of Anterior Cingulate Gyrus Activation in Unipolar and Bipolar Depression: an fMRI and Pattern Classification Approach (2017) (54)
Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia (2013) (54)
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression (2015) (53)
Serotonin transporter gene methylation is associated with hippocampal gray matter volume (2014) (53)
SPIDER OR NO SPIDER? NEURAL CORRELATES OF SUSTAINED AND PHASIC FEAR IN SPIDER PHOBIA (2015) (52)
Association of Brain Cortical Changes With Relapse in Patients With Major Depressive Disorder (2018) (52)
20-Item Toronto Alexithymia Scale: do difficulties describing feelings assess proneness to shame instead of difficulties symbolizing emotions? (2000) (52)
Care complexity in the general hospital: results from a European study. (2001) (52)
Slow EEG potentials (contingent negative variation and post-imperative negative variation) in schizophrenia: their association to the present state and to Parkinsonian medication effects (1999) (52)
Alcoholism and psychiatric comorbidity in general hospital inpatients. (1996) (52)
Serotonin receptor 1A −1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression? (2008) (51)
Production of interferon-gamma in families with multiple occurrence of schizophrenia (1997) (51)
Neural correlates of set-shifting: decomposing executive functions in schizophrenia. (2010) (50)
The PHF21B gene is associated with major depression and modulates the stress response (2016) (50)
Attachment style and oxytocin receptor gene variation interact in influencing social anxiety (2016) (50)
The relationship between psychological dimensions of depressive symptoms and cognitive functioning in the elderly - the MEMO-Study. (2007) (49)
Automatic brain response to facial emotion as a function of implicitly and explicitly measured extraversion (2010) (49)
Brain correlates of hypnotic paralysis—a resting-state fMRI study (2011) (49)
Complicated grief in patients with unipolar depression. (2009) (49)
Enhanced neural responsiveness to reward associated with obesity in the absence of food‐related stimuli (2015) (48)
Complicated grief after traumatic loss: a 14-month follow up study. (2007) (48)
NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression (2015) (47)
ADORA2A Gene Variation, Caffeine, and Emotional Processing: A Multi-level Interaction on Startle Reflex (2012) (47)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depressive disorder (2017) (47)
A brief diagnostic screening instrument for mental disturbances in general medical wards. (2004) (47)
Testing for linkage of eye tracking dysfunction and schizophrenia to markers on chromosomes 6, 8, 9, 20, and 22 in families multiply affected with schizophrenia. (1999) (47)
Monocyte activation, brain‐derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow‐up study from adolescence into adulthood (2015) (46)
Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia (2008) (46)
Magnetoencephalographic Correlates of Emotional Processing in Major Depression Before and After Pharmacological Treatment (2015) (46)
Detection of facial expressions of emotions in schizophrenia (2003) (46)
Cytokine production in unmedicated and treated schizophrenic patients (2000) (45)
Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response (2014) (45)
Multimodal imaging of a tescalcin (TESC)-regulating polymorphism (rs7294919)-specific effects on hippocampal gray matter structure (2014) (45)
Major depressive disorder: Findings of reduced homotopic connectivity and investigation of underlying structural mechanisms (2016) (45)
Systematic misestimation of machine learning performance in neuroimaging studies of depression (2019) (44)
Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobia. (2013) (44)
Bupropion as Add-On Strategy in Difficult-to-Treat Bipolar Depressive Patients (2002) (43)
Masked facial affect priming is associated with therapy response in clinical depression (2006) (43)
A longitudinal approach to biological psychiatric research: The PsyCourse study (2018) (42)
Risk factors for complex care needs in general medical inpatients: results from a European study. (2001) (41)
Schizophrenia spectrum disorders and eye tracking dysfunction in singleton and multiplex schizophrenia families (2003) (41)
Cognitive coping style modulates neural responses to emotional faces in healthy humans: a 3-T FMRI study. (2007) (41)
The functional −1019C/G HTR1A polymorphism and mechanisms of fear (2014) (39)
Alterations of the Innate Immune System in Susceptibility and Resilience After Social Defeat Stress (2018) (39)
Effects of electroconvulsive therapy on amygdala function in major depression – a longitudinal functional magnetic resonance imaging study (2017) (38)
Elevated body-mass index is associated with reduced white matter integrity in two large independent cohorts (2018) (38)
Differing brain structural correlates of familial and environmental risk for major depressive disorder revealed by a combined VBM/pattern recognition approach (2015) (38)
The Lübeck General Hospital Study. I: Prevalence of psychiatric disorders in medical and surgical inpatients. (1997) (38)
Evidence from increased anticipation of predictive saccades for a dysfunction of fronto-striatal circuits in obsessive–compulsive disorder (2006) (38)
Eye-tracking dysfunction (ETD) in families with sporadic and familial schizophrenia (2000) (38)
CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder? (2017) (37)
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder (2020) (37)
GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder (2017) (37)
Subliminal affective priming in clinical depression and comorbid anxiety: A longitudinal investigation (2006) (36)
Quantitative analysis of eye movements in schizophrenia (1990) (36)
Anti-NMDA-Rezeptor-Enzephalitis (2010) (36)
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials (2021) (36)
Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations (2020) (36)
Reduced implicit and explicit sequence learning in first-episode schizophrenia (2008) (35)
Association of MAO-A Variant with Complicated Grief in Major Depression (2008) (35)
Depression and suicidality: A link to premature T helper cell aging and increased Th17 cells (2020) (35)
Evidence of an IFN-γ by early life stress interaction in the regulation of amygdala reactivity to emotional stimuli (2015) (35)
An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study. (2020) (34)
Separating depressive comorbidity from panic disorder: A combined functional magnetic resonance imaging and machine learning approach. (2015) (34)
Attention training in the cognitive rehabilitation of schizophrenic patients: a review of efficacy studies. (2001) (33)
Negative Impact of Self-Stigmatization on Attitude Toward Medication Adherence in Patients with Psychosis (2014) (33)
Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease (2017) (33)
Smooth pursuit deficits in schizophrenia, affective disorder and obsessive–compulsive disorder (2004) (33)
Anterior cingulate cortex activation is related to learning potential on the WCST in schizophrenia patients (2012) (33)
The Influence of Typical and Atypical Neuroleptic Drugs in the Production of Interleukin-2 and Interferon-Gamma in vitro (2003) (33)
Anxious versus non-anxious depression: difference in treatment outcome (2010) (33)
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response (2016) (33)
Depression Does Not Affect the Treatment Outcome of CBT for Panic and Agoraphobia: Results from a Multicenter Randomized Trial (2012) (32)
Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression (2004) (32)
Neuropeptide S receptor (NPSR1) gene variation modulates response inhibition and error monitoring (2013) (32)
Alexithymia and automatic processing of verbal and facial affect stimuli (2001) (31)
Effects of cumulative illness severity on hippocampal gray matter volume in major depression: a voxel-based morphometry study (2018) (31)
The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder (2018) (31)
Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters (1998) (31)
High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib (2017) (31)
Optimizing exposure‐based CBT for anxiety disorders via enhanced extinction: Design and methods of a multicentre randomized clinical trial (2017) (31)
Therapygenetics: anterior cingulate cortex–amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia (2014) (30)
Anticipating agoraphobic situations: the neural correlates of panic disorder with agoraphobia (2014) (30)
Does rTMS Alter Neurocognitive Functioning in Patients with Panic Disorder/Agoraphobia? An fNIRS-Based Investigation of Prefrontal Activation during a Cognitive Task and Its Modulation via Sham-Controlled rTMS (2014) (30)
Dopamine D₃ receptor gene variation: impact on electroconvulsive therapy response and ventral striatum responsiveness in depression. (2013) (30)
Automatic processing of verbal emotion stimuli in schizophrenia (2003) (30)
Adult attachment avoidance and automatic affective response to sad facial expressions (2010) (30)
Threat sensitivity as assessed by automatic amygdala response to fearful faces predicts speed of visual search for facial expression (2007) (30)
Effects of ADORA2A gene variation and caffeine on prepulse inhibition: A multi-level risk model of anxiety (2013) (29)
RGS2 genetic variation: Association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety (2015) (29)
The cerebral hemodynamics of repetitive transcranial magnetic stimulation (2000) (29)
Acute Shift in Glutamate Concentrations Following Experimentally Induced Panic with Cholecystokinin Tetrapeptide—A 3T-MRS Study in Healthy Subjects (2013) (29)
Association of Adenosine Receptor Gene Polymorphisms and In Vivo Adenosine A1 Receptor Binding in The Human Brain (2014) (29)
COMT val158met influence on electroconvulsive therapy response in major depression (2009) (29)
Increased serum neopterin levels in acutely ill and recovered schizophrenic patients (1998) (28)
Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults (2018) (28)
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder (2018) (28)
[Psychiatric consultation service in a university clinic. An empirical study of characteristic performance]. (1995) (28)
Automatic amygdala response to facial expression in schizophrenia: initial hyperresponsivity followed by hyporesponsivity (2013) (28)
Search for atypical lymphocytes in schizophrenia (2004) (27)
Human nuclear transcription factor gene CREM: Genomic organization, mutation screening, and association analysis in panic disorder (2003) (27)
Timing of psychoeducational psychotherapeutic interventions in schizophrenic patients (2002) (27)
Prenatal immune activation in mice blocks the effects of environmental enrichment on exploratory behavior and microglia density (2016) (27)
Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples (2018) (27)
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders (2019) (27)
Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression (2019) (27)
Neural Correlates of Procedural Variants in Cognitive-Behavioral Therapy: A Randomized, Controlled Multicenter fMRI Study (2014) (27)
Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders (2018) (27)
Social Alienation in Schizophrenia Patients: Association with Insula Responsiveness to Facial Expressions of Disgust (2014) (26)
The Effects of Dysthymic Disorder on Health-Related Quality of Life and Disability Days in Persons with Comorbid Medical Conditions in the General Population (2009) (26)
Memory Performance in Severely Depressed Patients Treated by Electroconvulsive Therapy (2006) (26)
Depression and social functioning in general hospital in-patients. (1998) (26)
Target anticipation and impairment of smooth pursuit eye movements in schizophrenia (1998) (26)
The effects of processing speed on memory impairment in patients with major depressive disorder (2019) (26)
Therapeutic strategies for catatonia in paraneoplastic encephalitis (2008) (26)
Prevalence, 12-Month Prognosis, and Clinical Management Need of Depression in Coronary Heart Disease Patients: A Prospective Cohort Study (2019) (26)
Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression (2020) (26)
Alexithymia and Incidental Learning of Emotional Words (2003) (25)
Low left amygdala volume is associated with a longer duration of unipolar depression (2018) (25)
Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks (2018) (25)
[Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture]. (2010) (25)
Prefrontal brain responsiveness to negative stimuli distinguishes familial risk for major depression from acute disorder (2017) (25)
Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy (2017) (25)
Social Defeat Modulates T Helper Cell Percentages in Stress Susceptible and Resilient Mice (2019) (25)
Grief after termination of pregnancy due to fetal malformation (2004) (25)
Automatic processing of facial emotion in schizophrenia with and without affective negative symptoms (2005) (24)
Gender Differences in Associations of Glutamate Decarboxylase 1 Gene (GAD1) Variants with Panic Disorder (2012) (24)
Genetic comorbidity between major depression and cardio-metabolic disease, stratified by age at onset of major depression (2019) (24)
Association analysis of Rgs7 variants with panic disorder (2009) (23)
Impaired spatial learning and reduced adult hippocampal neurogenesis in histamine H1-receptor knockout mice (2014) (23)
Noninvasive stimulation of the ventromedial prefrontal cortex modulates emotional face processing (2018) (23)
MicroRNA hsa‐miR‐4717‐5p regulates RGS2 and may be a risk factor for anxiety‐related traits (2015) (23)
Severe Tardive Dyskinesia in Affective Disorders: Treatment with Vitamin E and C (2003) (23)
The genetic relationship between educational attainment and cognitive performance in major psychiatric disorders (2019) (22)
Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder (2018) (22)
Dysbindin (DTNBP1)--a role in psychotic depression? (2011) (22)
Acute anxiolytic effects of quetiapine during virtual reality exposure—A double-blind placebo-controlled trial in patients with specific phobia (2013) (22)
Association between heart-focused anxiety, depressive symptoms, health behaviors and healthcare utilization in patients with coronary heart disease. (2020) (22)
Cortical surface area alterations shaped by genetic load for neuroticism (2018) (22)
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes (2019) (22)
Smooth pursuit performance in families with multiple occurrence of schizophrenia and nonpsychotic families (1999) (21)
Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression (2013) (21)
Affect-Modulated Startle: Interactive Influence of Catechol-O-Methyltransferase Val158Met Genotype and Childhood Trauma (2012) (21)
Support Vector Machine Analysis of Functional Magnetic Resonance Imaging of Interoception Does Not Reliably Predict Individual Outcomes of Cognitive Behavioral Therapy in Panic Disorder with Agoraphobia (2017) (21)
Diagnostic classification of unipolar depression based on resting-state functional connectivity MRI: effects of generalization to a diverse sample (2017) (21)
Brain-Derived Neurotrophic Factor (Bdnf) and Gray Matter Volume in Bipolar Disorder (2017) (21)
The mirror neuron system under hypnosis – Brain substrates of voluntary and involuntary motor activation in hypnotic paralysis (2013) (21)
S100B overexpression increases behavioral and neural plasticity in response to the social environment during adolescence. (2013) (21)
MANIA—A Pattern Classification Toolbox for Neuroimaging Data (2014) (21)
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic) (2019) (20)
De novo onset of Parkinson's disease after antidepressant treatment with citalopram. (2000) (20)
Visual backward masking: Deficits in locating targets are specific to schizophrenia and not related to intellectual decline (2005) (20)
Implicit and explicit procedural learning in patients recently remitted from severe major depression (2009) (20)
Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach (2013) (20)
Stem Cell Factor (SCF) is a putative biomarker of antidepressant response (2016) (20)
Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression (2020) (20)
Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic (2015) (19)
Pretreatment Cardiac Vagal Tone Predicts Dropout from and Residual Symptoms after Exposure Therapy in Patients with Panic Disorder and Agoraphobia (2018) (19)
Identifying the Common Genetic Basis of Antidepressant Response (2021) (19)
[A critique of the construct "alexithymia" and its measurement--the weakness of self-report and the opportunities of an objective assessment approach]. (2001) (19)
Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity (2019) (19)
Paranoid schizophrenia: non-specificity of neuropsychological vulnerability markers (1997) (19)
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study (2018) (19)
Molecular serum signature of treatment resistant depression (2016) (19)
Relations between Neuropsychological Vulnerability Markers and Negative Symptoms in Schizophrenia (1998) (19)
Serum brain-derived neurotrophic factor and stability of depressive symptoms in coronary heart disease patients: A prospective study (2017) (18)
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression (2019) (18)
Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates (2008) (18)
Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation (2012) (18)
The relationship between social cognition and executive function in Major Depressive Disorder in high-functioning adolescents and young adults (2018) (18)
Medical Comorbidity Affects Antidepressant Treatment Response in Patients with Melancholic Depression (2009) (18)
Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank (2019) (18)
Psychiatric Comorbidity in Hospitalized Alcoholics after Detoxification Treatment (1996) (17)
Influence of electroconvulsive therapy on white matter structure in a diffusion tensor imaging study (2019) (17)
Altered auditory processing in patients with panic disorder: A pilot study (2010) (17)
Childhood maltreatment moderates the influence of genetic load for obesity on reward related brain structure and function in major depression (2019) (17)
Facing the fear – clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia (2016) (17)
The Influence of Familial Loading on the Course of Schizophrenic Symptoms and the Success of Psychoeducational Therapy (2001) (17)
The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients. (2004) (16)
TNF receptors 1 and 2 exert distinct region‐specific effects on striatal and hippocampal grey matter volumes (VBM) in healthy adults (2017) (16)
[The research network PANIC-NET: improving the treatment of panic disorder - from a better understanding of fear circuit mechanisms to more effective psychological treatment and routine care]. (2009) (16)
hSKCa3: a candidate gene for schizophrenia? (1999) (16)
Mental disturbances and perceived complexity of nursing care in medical inpatients: results from a European study. (2001) (15)
Backward masking in schizophrenia: time course of visual processing deficits during task performance (1998) (15)
KPNA3 Variation Is Associated with Schizophrenia, Major Depression, Opiate Dependence and Alcohol Dependence (2012) (15)
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression (2021) (15)
Effect of CBT on Biased Semantic Network in Panic Disorder: A Multicenter fMRI Study Using Semantic Priming. (2019) (15)
Hypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder? (2016) (15)
Commonalities and differences in the neural substrates of threat predictability in panic disorder and specific phobia (2017) (14)
Effect of Acute Stressor and Serotonin Transporter Genotype on Amygdala First Wave Transcriptome in Mice (2013) (14)
Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fears (2014) (14)
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. (2015) (14)
The effect of childhood trauma on serum BDNF in bipolar depression is modulated by the serotonin promoter genotype (2017) (14)
Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study (2020) (14)
Of ‘Disgrace’ and ‘Pain’ – Corticolimbic Interaction Patterns for Disorder-Relevant and Emotional Words in Social Phobia (2014) (13)
Reduced locomotor activity and exploratory behavior in CC chemokine receptor 4 deficient mice (2016) (13)
The role of treatment delivery factors in exposure-based cognitive behavioral therapy for panic disorder with agoraphobia. (2016) (13)
Hypermethylation of the serotonin transporter gene promoter in panic disorder–Epigenetic imprint of comorbid depression? (2019) (13)
A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety (2018) (13)
Impact of electroconvulsive therapy on magnetoencephalographic correlates of dysfunctional emotional processing in major depression (2016) (13)
Anti-NMDA-Rezeptor-Enzephalitis (2010) (13)
Neural correlates of individual differences in anxiety sensitivity: an fMRI study using semantic priming. (2016) (13)
Noninvasive Stimulation of the Ventromedial Prefrontal Cortex Indicates Valence Ambiguity in Sad Compared to Happy and Fearful Face Processing (2019) (12)
Update Anti-N-Methyl-D-Aspartat-Rezeptor-Enzephalitis (2017) (12)
Impact of major depressive disorder, distinct subtypes, and symptom severity on lifestyle in the BiDirect Study (2016) (12)
GENDER‐SPECIFIC ASSOCIATION OF VARIANTS IN THE AKR1C1 GENE WITH DIMENSIONAL ANXIETY IN PATIENTS WITH PANIC DISORDER: ADDITIONAL EVIDENCE FOR THE IMPORTANCE OF NEUROSTEROIDS IN ANXIETY? (2014) (12)
The role of BDNF methylation and Val66Met in amygdala reactivity during emotion processing (2019) (12)
The importance of strengthening competence and control beliefs in patients with psychosis to reduce treatment hindering self-stigmatization (2017) (12)
Unimpaired automatic processing of verbal information in the course of clinical depression (2006) (11)
Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment. (2003) (11)
Have we met before? Neural correlates of emotional learning in women with social phobia. (2014) (11)
Multilevel impact of the dopamine system on the emotion-potentiated startle reflex (2015) (11)
The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features (2007) (11)
S100B Serum Levels and Word Memory Processing in Remitted Major Depression as Reflected by Brain Potentials (2009) (11)
Biological sex classification with structural MRI data shows increased misclassification in transgender women (2019) (11)
Incidental learning of food and emotional words in women with anorexia nervosa (2004) (11)
Immunological research in clinical psychiatry: report on the consensus debate during the 7th expert meeting on psychiatry and immunology (2002) (11)
Efficacy of temporally intensified exposure for anxiety disorders: A multicenter randomized clinical trial (2021) (11)
Neural adaptation of cingulate and insular activity during delayed fear extinction: A replicable pattern across assessment sites and repeated measurements (2020) (10)
Outpatient Psychotherapy for Mothers—First Empirical Results (2003) (10)
Basal Prolactin Values Correlate with Response to Reboxetine Treatment in Major Depression, but Not with Response to Citalopram (2005) (10)
Modulation of defensive reactivity by GLRB allelic variation: converging evidence from an intermediate phenotype approach (2017) (10)
Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum (2020) (10)
Affective temperaments (TEMPS-A) in panic disorder and healthy probands: Genetic modulation by 5-HTT variation (2019) (10)
[Psychiatric and psychosomatic consulation-liaison. An overview]. (2013) (10)
[Attitudes towards using eHealth in psychiatry and psychotherapy : A pilot survey at the DGPPN Congress 2014]. (2016) (10)
A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine (2009) (9)
"Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT": Correction to Gloster et al. (2011). (2011) (9)
Change of Threat Expectancy as Mechanism of Exposure-Based Psychotherapy for Anxiety Disorders: Evidence From 8,484 Exposure Exercises of 605 Patients (2022) (9)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression (2009) (9)
Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses (2021) (9)
The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia. (2019) (9)
Prepare for scare—Impact of threat predictability on affective visual processing in spider phobia (2016) (8)
[The course of infantile autism through adulthood. An overview of long-term follow-up data]. (2001) (8)
Brain-derived Neurotrophic Factor, Depressive Symptoms, and Somatic Comorbidity in Patients with Coronary Heart Disease. (2020) (8)
[Alexithymia and automatic activation of emotional-evaluative information]. (1998) (8)
Eye tracking dysfunction in families with multiple cases of schizophrenia (2005) (8)
Outpatient psychotherapy for mothers – a new treatment (2003) (8)
Virtual Ontogeny of Cortical Growth Preceding Mental Illness (2022) (8)
6th International Conference on the Reduction of Drug-Related Harm (1996) (8)
[Measures of grief--a critical review]. (2003) (7)
Effects of Cognitive Behavioral Therapy on Neural Processing of Agoraphobia-Specific Stimuli in Panic Disorder and Agoraphobia (2018) (7)
Association of NPSR1 gene variation and neural activity in patients with panic disorder and agoraphobia and healthy controls (2019) (7)
Confounding diagnostic systems: a major risk in the use of criteria-based manuals. (1994) (7)
The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts. (2015) (7)
[Effectiveness of computer-assisted attention training of schizophrenic patients]. (1998) (7)
Depressive symptoms and health care within 30 days after discharge from a cardiac hospital unit. (2019) (7)
Evidence of increased risk for major depressive disorder in individuals homozygous for the high-expressing 5-HTTLPR/rs25531 (L(A)) allele of the serotonin transporter promoter. (2013) (7)
No evidence of DISC1-associated morphological changes in the hippocampus, anterior cingulate cortex, or striatum in major depressive disorder cases and healthy controls. (2014) (7)
CHAPTER 27 – Schizophrenia and Immunity (2007) (6)
The question of pro-inflammatory immune activity in schizophrenia and the potential importance of anti-inflammatory drugs. (2013) (6)
Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study (2020) (6)
Alterations in B cell subsets correlate with body composition parameters in female adolescents with anorexia nervosa (2021) (6)
[Diagnostic Accuracy of German Depression Screenings in Patients with Coronary Heart Disease]. (2017) (6)
Influence of Repressive Coping Style on Cortical Activation during Encoding of Angry Faces (2014) (6)
Time heals all wounds? A 2-year longitudinal diffusion tensor imaging study in major depressive disorder (2019) (6)
[Late-onset depression : Pathophysiology, diagnostics and treatment]. (2016) (6)
Differences in P3 amplitudes between schizophrenics and healthy controls vary between the different events presented in a guessing task. (1994) (6)
Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits (2022) (5)
Transfer of exposure therapy effects to a threat context not considered during treatment in patients with panic disorder and agoraphobia: Implications for potential mechanisms of change. (2021) (5)
Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients (2020) (5)
Brain structural correlates of alexithymia in patients with major depressive disorder (2020) (5)
Prevalence of psychiatric disorders in physically ill patients. (2004) (5)
Emotional processing and rTMS: does inhibitory theta burst stimulation affect the human startle reflex? (2016) (4)
[Neurogenetics of emotional processes. Neuroimaging findings as endophenotypes for depression]. (2010) (4)
Amygdala activation during masked presentation of emotional faces (2005) (4)
[Anti-NMDA receptor encephalitis: an important differential diagnosis of catatonia in young psychiatric patients]. (2013) (4)
Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms (2019) (4)
Vagal control of the heart decreases during increasing imminence of interoceptive threat in patients with panic disorder and agoraphobia (2021) (4)
Naturalistic Pharmacotherapy of Acute Episodes of Schizophrenic Disorders in Comparison to Treatment Guidelines (2012) (4)
A genome-wide association study of the longitudinal course of executive functions (2021) (4)
Polygenic risk scores across the extended psychosis spectrum (2021) (4)
The modulating impact of cigarette smoking on brain structure in panic disorder: a voxel-based morphometry study (2020) (4)
Therapist adherence to a treatment manual influences outcome and dropout rates: Results from a multicenter randomized clinical CBT trial for panic disorder with agoraphobia (2013) (4)
[New discoveries call for new therapies in attention-deficit hyperactivity disorder]. (2008) (4)
[Incidence and treatment requirements of alcoholism in internal medicine and hospital patients]. (1995) (4)
[German and American consultant psychiatrists evaluate their function. A contribution to quality improvement in consultation psychiatry]. (1997) (3)
[Therapeutic factors of outpatient group psychotherapy - the predictive validity of the Group Experience Questionnaire (GEQ)]. (2002) (3)
Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia (2019) (3)
Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation (2017) (3)
[Diagnosis and treatment of depressive syndromes in general practice of established neurologists. Results of an empirical study]. (1993) (3)
[Implementation and evaluation of a revised curriculum for psychiatry and psychotherapy]. (2019) (3)
Influence of single-dose quetiapine on fear network activity – A pharmaco-imaging study (2017) (3)
A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank (2020) (3)
Anxiety disorders and post-traumatic stress disorder in patients with coronary heart disease (2020) (3)
Reduced amygdala-prefrontal connectivity is associated with symptom severity in major depression (2007) (3)
[Depressive disorders with somatic illnesses]. (2003) (3)
Effective-and Tolerable: Acceptance and Side Effects of Intensified Exposure for Anxiety Disorders. (2022) (2)
Association of 5-HTTLPR/rs25531 with depressive symptoms in patients with coronary heart disease: A prospective study. (2020) (2)
[Schizophrenia-like personality disorders]. (2009) (2)
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis (2021) (2)
Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis (2020) (2)
Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers (2022) (2)
P.4.b.00l Neuropeptide S receptor (NPSR) gene – imaging genetic evidence for a role in panic disorder (2010) (2)
Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response (2007) (2)
Neuroplasticity in major depression may be indicated by S100B (2002) (2)
A case of multiple sclerosis masked by depression and diabetic neuropathy. (2006) (2)
Structural and functional neural correlates of vigilant and avoidant regulation style. (2019) (2)
The endocannabinoid system in humans: significant associations between anandamide, brain function during reward feedback and a personality measure of reward dependence (2020) (2)
Inflammatory monocyte activation is associated with natural T regulatory cell deficiencies and co-occurs with cellular immune defects in major depressive disorder (2016) (2)
[Disorders of eye movements in schizophrenia--a critical review and future perspectives]. (1993) (2)
[Indications for psychiatric consultation: a case-specific parallel survey of psychiatrists and treating physicians]. (1993) (2)
Serum brain-derived neurotrophic factor and depressive symptoms in coronary heart disease patients: Role of cognitive functions (2017) (2)
Cortical abnormalities in bipolar disorder ENIGMA Bipolar Disorder Working (2018) (2)
The COMT val158met genetic variant predicts antidepressant treatment response in major depression (2006) (2)
[Diagnostic work-up and treatment of acute psycho-organic syndrome]. (2010) (2)
Limbic scars : Functional and structural MRI reveal long-term consequences of childhood maltreatment (2011) (1)
[The immunology of psychiatric disorders]. (2005) (1)
P.4.a.002 Hypomethylation of corticotropin releasing hormone receptor 1 promoter region: Converging evidence for a role in panic disorder (2016) (1)
P-125 - Epigenetics of Panic Disorder - Evidence for Mao-a Gene Hypomethylation (2012) (1)
COGNITIVE COPING STYLE MODULATES NEURAL RESPONSES TO EMOTIONAL FACES – A 3 T FMRI STUDY (2007) (1)
P.2.c.030 The COX-2 inhibitor celecoxib has therapeutic effects in major depression:results of a double-blind, placebo controlled, add-on study to reboxetine (2006) (1)
Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder. (2022) (1)
[The spectrum of bipolar disorders]. (2003) (1)
Interferon-? in Schizophrenia (1997) (1)
Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology and (2016) (1)
[Disorders of early information processing and vigilance as vulnerability markers for schizophrenia]. (1996) (1)
Serotonin-transporter polymorphism modulates anterior cingulate cortex activation during working memory tasks – an fMRI study (2011) (1)
Ziprasidone in the treatment of major depressive disorder with psychotic features (2005) (1)
Immunocompetent Cells in Melancholic and Non-Melancholic Major Depression (2001) (1)
Sometimes I feel the fear of uncertainty: How intolerance of uncertainty and trait anxiety impact fear acquisition, extinction and the return of fear. (2022) (1)
Correction: Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank (2020) (1)
The effect of distraction on smooth pursuit eye movements: comparison of normal subjects with schizophrenic patients (1999) (1)
Interplay between the genetics of personality traits, severe psychiatric disorders and COVID-19 host genetics in the susceptibility to SARS-CoV-2 infection (2021) (1)
An investigation of genetic variability of DNA methyltransferases DNMT3A and 3B does not provide evidence for a major role in the pathogenesis of panic disorder and dimensional anxiety phenotypes (2020) (1)
Allelic variation in CRHR 1 predisposes to panic disorder by biasing towards fear (2015) (1)
Prediction of unipolar and bipolar depression on the basis of pattern classification techniques using amygdala excitability to subliminally presented emotional faces (2013) (1)
Assessment and follow-up of suicidal ideation when screening for depression in hospitalized coronary heart disease patients – development of a protocol (2015) (1)
Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation (2012) (1)
Impaired water-maze performance and altered adult hippocampal neurogenesis in histamine H1-receptor knockout mice (2011) (1)
[Psychotherapy of depression in general practice of established psychiatrists: results of an empirical study]. (1994) (1)
IMPLICIT SEQUENCE LEARNING IN SCHIZOPHRENIA INVESTIGATED WITH FUNCTIONAL MRI (2008) (1)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome (2011) (1)
Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex (2016) (1)
[Psychiatric epidemiology and public health medicine. Principles of health service research]. (2005) (1)
Amygdala response during automatic processing of facial emotion in schizophrenia and its association with psychopathology: a 3-T fMRI study (2008) (1)
Clinical and Neurofunctional Substrates of Cognitive Behavioral Therapy on Secondary Social Anxiety Disorder in Primary Panic Disorder: A Longitudinal fMRI Study (2018) (1)
Chapter 5 Monocyte activation , brain-derived neurotrophic factor ( Bdnf ) , and s 100 B in bipolar offspring : a follow-up study from adolescence into adulthood (2018) (1)
S.14.04 The role of (epi)genetics in antidepressant drug efficacy (2016) (1)
Neural correlates of NOS1 ex1f-VNTR allelic variation in panic disorder and agoraphobia during fear conditioning and extinction in fMRI (2020) (1)
Association between mitochondria-related genes and cognitive performance in the PsyCourse Study. (2023) (1)
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B (2004) (1)
[A special case of attempted double suicide]. (1986) (1)
Genome-wide association for major depression through age at onset stratificationGenomic analysis of age at onset in depression (2016) (1)
Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain (2012) (1)
3. The Mild Encephalitis subgroup of schizophrenia - An update (2013) (0)
Quetiapine in the treatment of agitated depression (2007) (0)
Noncompliance and Its Control in Benzodiazepine Withdrawal (1997) (0)
[Which psychotherapy for whom?] (2018) (0)
118-PSYCHOSOCIAL CARE IN PRENATAL DIAGNOSTICS (2004) (0)
Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns (2019) (0)
Molecular serum signature of treatment resistant depression (2016) (0)
fMRI investigation of voluntary and involuntary motor activation in hypnotic paralysis (2010) (0)
P.4.a.003 Neural substrates of fear conditioning are modulated by GLRB allelic variation: converging evidence from an independent replication (2017) (0)
1. MDD symptoms in relation to monocyte activation (2013) (0)
613 – Glutamate Decarboxylase 1 DNA Hypomethylation - An Epigenetic Signature of Panic Disorder? (2013) (0)
[Development of neurobiology effects the future of psychotherapy]. (2001) (0)
EPA-1254 – Clinical profile of neurocognitive dysfunction in major depression (2014) (0)
Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders (2017) (0)
Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder (2023) (0)
High basal prolactin values predict response to reboxetine treatment in major depression (2004) (0)
Effects of psychosocial stress on the behavior of S100B transgenic mice (2011) (0)
[Comments on the letters to the editor of the leading topic volume "Complementary and alternative treatments in psychiatry"]. (2019) (0)
P.1.a.007 Monoamine oxidase A (MAOA) gene hypomethylation in panic disorder − an epigenetic risk pattern reversed by psychotherapy? (2016) (0)
LEARNING POTENTIAL IN SCHIZOPHRENIA IS RELATED TO NEURONAL INTEGRITY OF THE ANTERIOR CINGULATE CORTEX AS MEASURED BY PROTON MAGNETIC RESONANCE SPECTROSCOPY (2008) (0)
Cytokine production in unmedicated acutely psychotic schizophrenic patients and during treatment (2000) (0)
Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation (rTMS): An open study (1999) (0)
Depression symptoms in relation to inflammatory monocyte gene expression in patients with major depressive disorder (2013) (0)
Depressive symptoms and health care within 30 days after discharge from a cardiac hospital unit: Response letter to the editor. (2019) (0)
Expression of CXCR4 on CD4+ T cells predicts body composition parameters in female adolescents with anorexia nervosa (2022) (0)
P.1.001 Basal prolactin values correlate with response to reboxetine treatment in depressed patients, but not with response to citalopram (2004) (0)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture ofmajor depressive disorder (2018) (0)
Hormonal influences on cerebral networks for cognition demonstrated with fMRI at 3 T (2005) (0)
Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender women (2021) (0)
117-FACTORS INFLUENCING THE GRIEVING PROCESS AFTER TERMINATION OF PREGNANCY DUE TO FETAL ABNORMALITIES (2004) (0)
Erratum to “Finding of abnormal scanning behavior in the Span of Apprehension task in schizophrenia but diagnostic non-specificity of sum scores” [Eur Psychiatry 23 (2008) 29–32] (2009) (0)
Effects of Interoceptive Exposure in Cognitive-Behavioral Therapy of Panic Disorder with Agoraphobia (2016) (0)
Repressive coping style modulates neural responses during encoding of emotional faces (2010) (0)
S.15.01 Immune pathology in depression: the role of glia cells during the course of disease (2007) (0)
Subject Index Vol. 56, 2007 (2008) (0)
Psychoimmunological alterations in schizophrenia: how do confounding variables influence the findings? (1999) (0)
P01.138 The influence of familial loading on the course of schizophrenic symptoms and the success of psychoeducational therapy (2000) (0)
Alterations in B cell subsets correlate with body composition parameters in female adolescents with anorexia nervosa (2021) (0)
2-MENTAL DISORDERS AND PSYCHOLOGICAL PROBLEMS IN THE SOMATICALLY ILL—WE HAVE LEARNED A LOT ALREADY, BUT WHO CARES? (2004) (0)
23rd World Congress on Psychosomatic Medicine, Glasgow, 2015 (2014) (0)
P.4.d.006 Neural plasticity following cognitive-behavioral therapy in panic disorder – the impact of comorbid depression (2017) (0)
Does Inflammation Link Clinical Depression and Coronary Artery Disease (2018) (0)
Childhood trauma and overweight stratify patients with major depressive disorder in 4 separate immuno-metabolic endotypes (2022) (0)
Evidence for neuroplastic activity in acute schizophrenic psychosis (2002) (0)
Title Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group Permalink (2018) (0)
Neuropeptide S Receptor (NPSR) Gene - Converging Evidence for a Role in Panic Disorder (2020) (0)
P.1.a.001 Monoamine oxidase A DNA hypomethylation predicts impaired treatment response in depression (2013) (0)
Glucocorticoid sensitivity of the innate immune system in depression subtypes (2017) (0)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression (2018) (0)
119-COPING WITH A PREMATURE BIRTH: RESULTS OF A 14-MONTH FOLLOW-UP (2004) (0)
First-episode psychosis and direction of wave propagation at 1 Hz in the EEG (2006) (0)
Subject Index Vol. 78, 2009 (2009) (0)
Is schizophrenia an autoimmune disease? (1998) (0)
P.4.d.001 Developing fMRI markers for individual response prediction in panic disorder with agoraphobia: a machine-learning approach (2014) (0)
The Expression of Senescence, Inflammaging and Inflammatory Pyroptosis Genes in Monocytes of Major Depressed Patients. A Staging Immune Model of Major Depression Driven by Diagnosis, Sex, Adiposity and Childhood Adversity (2020) (0)
Editorial Board (2008) (0)
P.1.a.001 Impaired antidepressant treatment response – a role of serotonin transporter gene hypomethylation? (2014) (0)
A Comparison of Eye Movements in Families with Multiple Occurrence of Schizophrenia and Normal Families (1999) (0)
PHF21B Gene: Association with Major Depressive Disorder and Modulation of the Stress Response (2017) (0)
[Managing depressed patients in family practice. Helping the patient out of the emotional pit, without personally falling in]. (2002) (0)
[The Well-informed Patient: a Survey on Patients' Initiative in Seeking Disease-related Information]. (2022) (0)
DNA METHYLATION PATTERNS IN ANXIETY DISORDERS (2019) (0)
P.3.025 Brain-derived neurotrophic factor associates with gray matter volumes and early adverse experiences in bipolar disorder (2016) (0)
Finding of abnormal scanning behavior in the Span of Apprehension task in schizophrenia but diagnostic non-specificity of sum scores (2008) (0)
P.1.a.008 Oxytocin receptor gene hypomethylation as a potential risk factor in social anxiety? (2015) (0)
Higher body weight-dependent neural activation during reward processing. (2023) (0)
S.25.03 Neuroimaging effects of CBT on fear conditioning in panic disorder (2014) (0)
BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response (2011) (0)
Neural correlates of interference conflict in healthy participants and patients with mental disorders (2018) (0)
Correction: Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults (2020) (0)
[Attitudes towards depression and treatment options in patients with coronary heart disease]. (2019) (0)
Amygdala and prefrontal cortex emotional processing in panic disorder influenced by catechol-O-methyltransferase val158met genotype (2006) (0)
Multilevel impact of the dopamine system on the emotion-potentiated startle reflex (2014) (0)
Cytokines in schizophrenia. Results from a longitudinal study (1997) (0)
Gender and Addiction – Prevalence, Course and Treatment (1996) (0)
Edinburgh Research Explorer Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex (2017) (0)
FUNCTIONAL NEUROANATOMY OF THE WISCONSIN CARD SORTING TEST IN SCHIZOPHRENIC PATIENTS: AN EVENT-RELATED 3T fMRI STUDY (2008) (0)
Interplay between the Genetics of Personality Traits, severe Psychiatric Disorders, and COVID-19 Host Genetics in the Susceptibility to SARS-CoV-2 Infection - ADDENDUM (2021) (0)
Preliminary investigations on immune parameters in remitted patients with an affective disorder after amantadine treatment (2007) (0)
[Heart patient with depressive disorder. Proper treatment method]. (2001) (0)
MANIA—A Pattern Classification Toolbox for Neuroimaging Data (2014) (0)
Depression in medical patients. (2004) (0)
Effects of chronic social defeat on splenic chemokine expression and myeloid cell infiltration into the brain (2015) (0)
Neuropeptide S receptor gene variation modulates glutamatergic anterior cingulate cortex activity during CCK-4 induced panic (2015) (0)
Psychiatric patients with bipolar affective psychoses who receive lithiumprophylaxis risk to develop goiter with iodine deficiencydue to lithium induced ioduria. Moreover the incidence of other hthium (2010) (0)
Major depression is associated with automatic mood-congruent processing bias in the amygdala (2009) (0)
Gender and Hormone Levels Influence Cortical Activation during Synonym Generation . An fMRI Study across Menstrual Cycle and Sex at 3 (2005) (0)
depression and unhealthy lifestyle - Associations with diet, physical activity, body mass index, and smoking : 149/1126. (2015) (0)
Altered myeloid and lymphoid immune cell responses following repeated social defeat stress (2015) (0)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors (2009) (0)
[Primary and secondary negative symptoms: still a reliable differentiation? Comment on the contribution by W. Barnett. Ch. Mundt, P. Richter]. (1998) (0)
Automatic emotion processing in major depression: genes, brain, and cognitive bias (2008) (0)
P.2.020 Functional neuroimaging (ECD- Spect) in schizophrenia — changement in brain metabolism by atypical neuroleptics (1997) (0)
Sex-specific alterations in salivary α-amylase after awakening in major depression (2015) (0)
Linkage of eye tracking dysfunction to DNA-markers on chromosome 6p21 in schizophrenia (1998) (0)
[Obituary for prof. Dr. Rainer Tölle]. (2015) (0)
Identification of common genetic risk variants for autism spectrum disorder (2019) (0)
Event-dependent differences of P3 amplitudes between schizophrenics and healthy controls (1993) (0)
Motor phenotype assessment in patients with depressive disorders using isometric tongue force analysis – a readout for clinical studies? (2007) (0)
394. Progress in the search for schizophrenia susceptibility genes (1996) (0)
Stem Cell Factor (SCF) is a putative biomarker of antidepressant response (2016) (0)
Lithium-induced Hashimoto-Thyreoiditis: Therapeutical (1997) (0)
Visually-evoked event-related potentials and oral citalopram challenge test (2004) (0)
Contents Vol. 56, 2007 (2008) (0)
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions (2019) (0)
Chromosome 4 q 31-34 risk locus : association of neuropeptide Y Y 5 receptor variants with panic disorder (2008) (0)
Altered Auditive Processing as a Possible Trait-Marker of Major Depressive Disorder (2009) (0)
Improving Access to Psychological Therapies (IAPT) - An Open Gate to Treat Anxiety and Depression (2015) (0)
Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder (2018) (0)
Prediction of antidepressant treatment response - a pharmaco- and Imaging genetic contribution (2010) (0)
EFFECT OF COMT VAL108/158MET GENOTYPE ON EXECUTIVE FUNCTIONING IN SCHIZOPHRENIA (2008) (0)
[Persistent depressive mood and residual symptoms after depression. Often inconspicuous but still need to be treated]. (2010) (0)
Contents Vol. 78, 2009 (2009) (0)
P.2.a.004 The impact of ziprasidone on visually-evoked event-related potentials in depressed patients with psychotic features (2007) (0)
Eye tracking dysfunction (ETD) As a measurable indicator for the vulnerability to schizophrenia (1998) (0)
Cover Image, Volume 180B, Number 2, March 2019 (2019) (0)
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients (2004) (0)
[Mild cognitive disorders should not be treated lightly]. (2004) (0)
S.08.04 From candidate gene to (epi)genome-wide analysis of therapy response in adult anxiety disorders (2017) (0)
Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents (2017) (0)
Motor phenotype assessment in patients with depressive disorders using a force plate – a readout for clinical studies? (2008) (0)
[Termination of pregnancy for fetal abnormality--a traumatic experience?]. (2001) (0)
["Mild" cranio-cerebral trauma occasionally have grave psychic sequelae]. (2004) (0)
Subject Index Vol. 46, 2002 (2003) (0)
Automatic amygdala response to facial expression in schizophrenia: initial hyperresponsivity followed by hyporesponsivity (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Volkert Arolt?

Volkert Arolt is affiliated with the following schools:

University of Adelaide
University of Münster